1.38
price down icon2.13%   -0.03
after-market Handel nachbörslich: 1.37 -0.010 -0.72%
loading

Finanzdaten der Context Therapeutics Inc-Aktie (CNTX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Operating Income/Loss
76.49%
-9.7584
-5.5291 -4.3104 -18.70 -3.0885
Income/Loss From Continuing Operations Before Tax
92.86%
-8.8275
-4.5773 -28.96 1.2437 -2.2545
Income/Loss From Continuing Operations After Tax
92.86%
-8.8275
-4.5773 -3.3429 -17.46 -2.2545
Net Income/Loss
92.86%
-8.8275
-4.5773 -3.3429 -17.46 -2.2545
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
95.19
95.19 7.838 80.48 54.96
Diluted Average Shares
0.00%
95.19
95.19 7.838 80.48 54.96
Basic Earnings Per Share
80.00%
-0.09
-0.05 - -0.22 -0.04
Diluted Earnings Per Share
80.00%
-0.09
-0.05 - -0.22 -0.04
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$21.75
price down icon 5.15%
$85.96
price up icon 1.45%
$32.75
price up icon 0.21%
$102.61
price up icon 0.30%
$161.38
price down icon 1.56%
biotechnology ONC
$320.94
price down icon 1.86%
Kapitalisierung:     |  Volumen (24h):